Singapore markets close in 4 hours 32 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
98.33-1.51 (-1.51%)
At close: 04:04PM EDT
98.25 -0.08 (-0.08%)
After hours: 07:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 172.20B
Enterprise value 179.67B
Trailing P/E 20.53
Forward P/E 20.88
PEG Ratio (5 yr expected) 15.58
Price/sales (ttm)3.84
Price/book (mrq)4.72
Enterprise value/revenue 3.94
Enterprise value/EBITDA 12.88

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-16.42%
S&P500 52-week change 3-16.16%
52-week high 3142.60
52-week low 397.91
50-day moving average 3106.89
200-day moving average 3116.77

Share statistics

Avg vol (3-month) 34.58M
Avg vol (10-day) 35.27M
Shares outstanding 51.75B
Implied shares outstanding 6N/A
Float 81.74B
% held by insiders 10.73%
% held by institutions 175.93%
Shares short (30 Aug 2022) 412.94M
Short ratio (30 Aug 2022) 43.31
Short % of float (30 Aug 2022) 40.76%
Short % of shares outstanding (30 Aug 2022) 40.74%
Shares short (prior month 28 Jul 2022) 413.84M

Dividends & splits

Forward annual dividend rate 41.88
Forward annual dividend yield 41.87%
Trailing annual dividend rate 31.86
Trailing annual dividend yield 31.86%
5-year average dividend yield 41.54
Payout ratio 438.41%
Dividend date 314 Nov 2022
Ex-dividend date 412 Oct 2022
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 18.78%
Operating margin (ttm)23.22%

Management effectiveness

Return on assets (ttm)8.96%
Return on equity (ttm)24.18%

Income statement

Revenue (ttm)45.55B
Revenue per share (ttm)25.81
Quarterly revenue growth (yoy)10.10%
Gross profit (ttm)25.01B
EBITDA 13.95B
Net income avi to common (ttm)8.52B
Diluted EPS (ttm)4.79
Quarterly earnings growth (yoy)69.70%

Balance sheet

Total cash (mrq)9.29B
Total cash per share (mrq)5.3
Total debt (mrq)16.84B
Total debt/equity (mrq)45.87
Current ratio (mrq)2.01
Book value per share (mrq)20.84

Cash flow statement

Operating cash flow (ttm)10.24B
Levered free cash flow (ttm)7.29B